Rare Stock Picks In October 2025 - From 26 Discerning Analysts

Healthcare - ImmunityBio (IBRX) is considered a speculative buy for aggressive investors, with significant upside potential driven by its lead therapy and promising early data from the t-haNK program [4] - UnitedHealth (UNH) is trading below its intrinsic value with a projected 20% upside, focusing on aggressive repricing of plans, expanding value-based care, and implementing AI to improve margins and operational efficiency [4] Financials - SLR Investment (SLRC) offers an attractive ~11% dividend yield, trades below book value, and is noted for its conservative leverage and above-average cash holdings among BDC peers [6] - Brighthouse Financial (BHF) is undervalued at 0.33x adjusted book value per share, with strong fundamentals highlighted by record annuity sales, robust capital ratios, and aggressive buybacks, indicating potential for 30-50%+ upside [6] - Upstart (UPST) is seen as having overly prudent guidance, with growth not fully priced in, supported by its AI-driven underwriting and rising conversion rates [7]